Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
General characteristics of study population, both total and sex-stratified. Categorical variables were expressed as frequencies (percentages). Continuous variables are expressed as means ± SD. Parameters | Total (n = 132) | Male (n = 10) | Female (n = 122) | p Value:: No treatment or vitamin D supplementation only | 55 (41.7%) | 4 (40%) | 51 (41.8%)
Source: Results table. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Dietary Calcium Intake in Patients Evaluated for Bone Fragility, with a Focus on Women Receiving Adjuvant Endocrine Therapy for Breast Cancer: A Single-Center Cross-Sectional Study
Source: Article title.
Patients were then divided into 3 groups: postmenopausal, including women with spontaneous menopause, without a history of fragility fracture; secondary osteoporosis, including subjects with well-defined clinical disorders (comprising BC on AET) potentially causing bone fragility even without an already confirmed diagnosis of osteoporosis or osteopenia; severe osteoporosis, including patients with at least one fragility fracture and without risk factors for secondary osteoporosis.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Dietary Calcium Intake in Patients Evaluated for Bone Fragility, with a Focus on Women Receiving Adjuvant Endocrine Therapy for Breast Cancer: A Single-Center Cross-Sectional Study
Cross-sectional study · Nutrients · 2026
Original publication title
Dietary Calcium Intake in Patients Evaluated for Bone Fragility, with a Focus on Women Receiving Adjuvant Endocrine Therapy for Breast Cancer: A Single-Center Cross-Sectional Study
© 2026 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: Background/Objectives
Adequate dietary calcium intake is essential for bone health. Despite this, calcium intake is still insufficient in many countries of the world. The study aims to provide information about dietary calcium intake of specific populations with bone fragility, with a particular focus on patients at risk of secondary osteoporosis due to adjuvant endocrine therapy (AET) for breast cancer (BC).
Source: Background/ObjectivesAbstract: Results
Patients were predominantly postmenopausal women, with severe osteoporosis (43.2%) or at risk of secondary osteoporosis (40.9%); 64.8% of patients evaluated for secondary osteoporosis were women on AET for BC. Total mean dietary calcium intake was 959 ± 396 mg/day. A lower intake was observed in younger patients with postmenopausal osteoporosis (848 ± 471 mg/day, p = 0.03). Patients with normal bone mineral density (631 ± 131 mg/day), without fragility fractures (906 ± 361), and evaluated for secondary osteoporosis (900 ± 364 mg/day) tended to have lower mean dietary calcium intake although without reaching statistical significance. Mean calcium intake was also lower than the recommended threshold in women on AET for BC (854 ± 345 mg/day).
Source: ResultsAbstract: Conclusions
Patients with bone fragility should be more encouraged to increase their dietary calcium intake. Attention must be paid to women with BC on AET, who have high fracture risk and should not be discouraged a priori from consuming selected dairy products (low-fat and fermented ones) and alternative calcium dietary sources.
Source: ConclusionsAuthors’ abstract
Background/Objectives:
Adequate dietary calcium intake is essential for bone health. Despite this, calcium intake is still insufficient in many countries of the world. The study aims to provide information about dietary calcium intake of specific populations with bone fragility, with a particular focus on patients at risk of secondary osteoporosis due to adjuvant endocrine therapy (AET) for breast cancer (BC).
Methods:
Data from 132 patients referred for the first time to the Osteoporosis and Bone Metabolism Diseases outpatient clinic of the Division of Endocrinology of the Azienda Ospedaliero-Universitaria delle Marche (Ancona, Italy) were collected. Dietary calcium intake was assessed with a 7-day food frequency questionnaire; biochemical and densitometric parameters, osteoporosis etiology, and previous fragility fractures were also reported.
Results:
Patients were predominantly postmenopausal women, with severe osteoporosis (43.2%) or at risk of secondary osteoporosis (40.9%); 64.8% of patients evaluated for secondary osteoporosis were women on AET for BC. Total mean dietary calcium intake was 959 ± 396 mg/day. A lower intake was observed in younger patients with postmenopausal osteoporosis (848 ± 471 mg/day, p = 0.03). Patients with normal bone mineral density (631 ± 131 mg/day), without fragility fractures (906 ± 361), and evaluated for secondary osteoporosis (900 ± 364 mg/day) tended to have lower mean dietary calcium intake although without reaching statistical significance. Mean calcium intake was also lower than the recommended threshold in women on AET for BC (854 ± 345 mg/day).
Conclusions:
Patients with bone fragility should be more encouraged to increase their dietary calcium intake. Attention must be paid to women with BC on AET, who have high fracture risk and should not be discouraged a priori from consuming selected dairy products (low-fat and fermented ones) and alternative calcium dietary sources.
Publication and source details
Original title: Dietary Calcium Intake in Patients Evaluated for Bone Fragility, with a Focus on Women Receiving Adjuvant Endocrine Therapy for Breast Cancer: A Single-Center Cross-Sectional Study
Francesca Firmani; Alessandro Ciarloni; Sofia Sabatelli; Claudio Gianfelice; Gianmaria Salvio; Veronica Agostinelli; Rossana Berardi; Giancarlo Balercia; Gilberta Giacchetti
Nutrients · 2026
* Correspondence: a.ciarloni@pm.univpm.it© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:35:54.131966+00:00
DOI: 10.3390/nu18193239 · PMC13666633